Showing 141 - 160 results of 9,182 for search '(( significantly higher decrease ) OR ( significantly ((better decrease) OR (between treated)) ))', query time: 0.52s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146

    AO/EtBr Staining of Cancer cell lines: <i>To check whether vitamin D3 promoted cell death in cancer cells, a dual staining protocol was implemented as detailed in the methods secti... by Vidya G. Bettada (22208808)

    Published 2025
    “…The data represents the mean of at least 3 different fields. Differences between control and vitamin D3 treated groups were calculated and the level of significance was assessed by GraphPad Prism. …”
  7. 147
  8. 148
  9. 149
  10. 150

    RNA sequencing analysis of EV-treated LECs. by Xiaoqin Li (1399105)

    Published 2025
    “…(D) Comparisons of expression levels of genes related to stemness, differentiation, and epithelial-mesenchymal transition (EMT) between the control and EV-treated groups. <i>n</i> = 3 biological replicates. …”
  11. 151

    Association between CTI and CVD. by Xinxin Xu (690528)

    Published 2025
    “…</p><p>Conclusion</p><p>Higher CTI (whether treated as a continuous or categorical variable) was significantly associated with an increased risk of CVD. …”
  12. 152

    Data Sheet 1_Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab.docx by Jaejun Lee (1449937)

    Published 2024
    “…This study explored the association between PD-L1 expression in TME and outcomes in HCC patients treated with atezolizumab plus bevacizumab (AB), emphasizing the implications of PD-L1 expression in both malignant and tumor-infiltrating cells.…”
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    S1 Data - by Bowen Deng (3123237)

    Published 2024
    “…Comparing to patients whose longitudinal trajectory of blood glucose conformed to class 1, those with class 2 (HR = 2.52, 95%CI: 1.79–3.53) or class 4 (HR = 3.53, 95%CI: 2.07–6.03) seemed to have higher risk of 30-day mortality. Additionally, these associations were also significant in aged ≥60 years old, female, male, NSTEMI, and STEMI subgroups (all <i>P</i><0.05).…”